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Abstract
Antibody responses are thought to play an important role in control of Schistosoma infections, yet little is known about the
phenotype and function of B cells in human schistosomiasis. We set out to characterize B cell subsets and B cell responses to
B cell receptor and Toll-like receptor 9 stimulation in Gabonese schoolchildren with Schistosoma haematobium infection.
Frequencies of memory B cell (MBC) subsets were increased, whereas naive B cell frequencies were reduced in the
schistosome-infected group. At the functional level, isolated B cells from schistosome-infected children showed higher
expression of the activation marker CD23 upon stimulation, but lower proliferation and TNF-a production. Importantly, 6-
months after 3 rounds of praziquantel treatment, frequencies of naive B cells were increased, MBC frequencies were
decreased and with the exception of TNF-a production, B cell responsiveness was restored to what was seen in uninfected
children. These data show that S. haematobium infection leads to significant changes in the B cell compartment, both at the
phenotypic and functional level.
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Introduction
Schistosomiasis is a major parasitic disease of humans in the
developing world, with over 200 million people infected
worldwide [1]. As with other chronic helminth infections,
schistosomes cause widespread immune activation and deregula-
tion leading to general T cell hyporesponsiveness supporting the
long term survival of the parasite and minimizing immunopa-
thology [2–4]. Resistance to schistosomiasis is only gradually
acquired and is attributed to cumulative exposure to infection
[5,6]. Mice vaccination experiments with radiation-attenuated S.
mansoni cercariae showed less protection against re-infection in
mMT B cell-deficient mice than in wild-type mice [7], and the
transfer of serum from infected rodents to naive animals can
protect against infection [8,9], suggesting that antibodies are
important for protection against infection. In human infection,
protective IgA, IgE and IgG levels have been demonstrated
against adult worm antigens [10,11], and resistance to (re-)
infection is correlated with an increased ratio between IgE and
IgG4 [12]. Furthermore, expression of CD23, the low affinity IgE
receptor which can be strongly up-regulated by IL-4 [13], is also
correlated with development of resistance to Schistosoma re-
infection [14,15]. While B lymphocytes support the establishment
of the strong Th2 profile associated with helminth infections [16],
more recently they have also been shown to play an active
regulatory role in the course of Schistosoma infections [17] mostly
effecting T cell responses.
In general, immunological memory is characterized by its ability
to respond more rapidly and robustly to re-infection and is
dependent on the generation and maintenance of memory B cells
(MBCs) [18]. Memory B cells, originally defined as CD27+ [19],
can be further characterized into additional subsets by co-staining
with IgD into non-switched MBCs (CD27+IgD+), switched MBCs
(CD27+IgD2) and double negative MBCs (CD272IgD2) [20].
Furthermore, co-staining with CD21 can be used to separate
classical MBCs (CD27+CD21+) from activated MBCs
(CD27+CD212) and atypical MBCs (CD272CD212) [21]. Based
on these markers, naive B cells can be classified as CD272IgD+or
CD272CD21+. Recent studies have shown that chronic HIV
infection [21,22] as well as exposure to and infection with P.
falciparum malaria [23,24] are associated with the expansion of
atypical or ‘exhausted’ MBCs (CD272CD212). These cells are
characterized by high expression of the inhibitory receptor FCRL4
[25,26], and it has been suggested that this population may
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contribute to diminished pathogen-specific antibody responses in
infected individuals. Other chronic infections such as hepatitis C
virus (HCV) [27] have also shown perturbations in the distribution
of peripheral B cells subsets, most notably within the memory B
cell compartment suggesting that MBCs may play a role in disease
pathogenesis as well as insufficient immune response to combat the
disease.
Ligation of the B cell receptor (BCR) by its cognate antigen
leads to the production of antibodies and, depending on the
cytokines produced by Th cells, to further antibody isotype
switching and affinity maturation. B cells can also express a
variety of innate receptors, most notably Toll-like receptors
(TLRs), and can play a significant role in innate immune
responses as B cells upregulate activation markers, proliferate
and secrete cytokines upon engagement of these receptors
[28,29]. Importantly, TLR stimulation can also potentiate the T
cell-dependent production of antibodies [30,31]. TLR9 is highly
expressed in human B cells and is ligated by bacterial DNA
motifs containing unmethylated CpG dinucleotides. Previous
studies have clearly demonstrated that TLR9 stimulation is
sufficient to directly induce both naive and memory B cell
proliferation and activation [32,33]. In addition, the role of B
cells in innate immune responses has gained further interest as
several studies have demonstrated a pathogenic role for B cells
independent of their ability to produce antibodies. For example,
systemic lupus erythematosus (SLE) and rheumatoid arthritis
(RA) are associated with abnormally increased pro-inflamma-
tory cytokine production by B cells, including TNF-a. Impor-
tantly TNF-a [34], along with more recently IL-17 [35], is also
one of the key cytokines involved in schistosome-induced
pathology [36,37].
Currently there is little information on the composition of the
peripheral blood B cell compartment or the concomitant adaptive
and innate functionality of B cells during the course of human
Schistosoma haematobium infection. In this study, we compared the
circulating B cell subsets in peripheral blood of schistosome-
infected and uninfected Gabonese schoolchildren and their B cell
response to BCR and TLR engagement.
Materials and Methods
Study population
In April 2008 we initiated a study to investigate the effect of S.
haematobium infection on B cell phenotype and function. Venous
heparinized blood was obtained from 56 school-aged children living
in Lambare´ne´ (Gabon), a semi-urban municipality or from its
surrounding villages in which Schistosoma haematobium infection is
endemic and has been previously described in detail [17,38,39]. S.
haematobium infection was determined prior to blood collection by
examining a filtrate of 10 ml of urine passed through a 12-mm-
poresize filter (Millipore). Children were classified S. haematobium-
infected if at least one S. haematobium egg was detected in the urine, or
uninfected if three consecutive urine samples were negative.
Infections with intestinal helminths Ascaris lumbricoides and Trichuris
trichiura were determined by analyzing one fresh stool sample using
the Kato-Katz method [40]. Hookworm larvae were determined in
a 7-day coproculture of the same stool sample [41]. Infection with
Plasmodium falciparum was determined by Giemsa-stained thick blood
smears [42]. After collection of blood samples, all S. haematobium-
infected children were treated with a single dose of praziquantel
(40 mg/kg) three times every two months. Intestinal helminth- and
malaria-infected children received respectively a single dose of
albendazole (400 mg) and an artemisinin-based combination
therapy as per the local guidelines. The study was approved by the
‘‘Comite´ d’Ethique Regional Independent de Lambare´ne´’’ (CERIL;
Nu06/08). Written informed consent was obtained from parents or
legal guardians of all schoolchildren participating in the study.
Cell isolation
PBMCs were isolated by Ficoll-Hypaque density gradient
centrifugation from 20 ml of heparinized blood. B cells were
isolated with anti-CD19 MicroBeads (Miltenyi Biotec). The
isolated B cells were routinely ,95% pure.
Immunoglobulin assays
Plasma samples were analyzed using the Bio-Plex Pro Assays
Immunoglobulin Isotyping Kit (Bio-Rad) for total IgM, IgG1,
IgG2, IgG3, IgG4 and IgA levels according to manufacturers’
recommendations. Levels of total IgE were measured by ELISA
according to manufacturers’ instructions (Allergopharma).
B cell stimulation, staining of CD23 and intracellular TNF-
a and Ki-67
Freshly isolated B cells were cultured in RPMI 1640 medium
(Invitrogen) supplemented with 10% FCS (Greiner Bio-One),
100 U/ml penicillin (Astellas), 10 mg/ml streptomycin, 1 mM
pyruvate and 2 mM L-glutamine (all from Sigma). B cells were
seeded at 16105 cells per well and stimulated for 48 hours with
2.5 mg/ml anti-human IgG+IgM (Jackson ImmunoResearch),
5 mg/ml CpG ODN 2006 (Invivogen) or anti-IgG/IgM+CpG.
To detect intracellular TNF-a, B cells were restimulated with
50 ng/ml PMA (Sigma-Aldrich), 2 mg/ml ionomycin (Sigma-
Aldrich), and 100 ng/ml ultrapure LPS (Invivogen) for 6 hours
with the final 4 hours in the presence of 10 mg/ml brefeldin A
(Sigma-Aldrich), followed by fixation with the FoxP3 fixation/
permeabilization kit (eBioscience) and frozen in RPMI supple-
mented with 20% FCS and 10% DMSO (Merck) and stored at
280uC until FACS analysis. After thawing, cells were permeabi-
lized (Permeabilization buffer, eBioscience) and labeled with
surface anti-CD10-PerCP/eF710 (SN5c, eBioscience), anti-
CD20-APC/eF780 (2H7, eBioscience), anti-CD21-FITC (LT21,
BioLegend), anti-CD23-PE/Cy7 (EBVCS2, eBioscience), anti-
CD27-APC (L128, BD Biosciences), and intracellular anti-Ki-67-
Author Summary
Schistosomiasis affects over 200 million people and
especially children in developing countries. It causes
general hyporesponsiveness of the immune system,
which until now has predominantly been described for
various T cell subsets as well as dendritic cells. B cells in
this context have not yet been investigated. To address
this question, we phenotyped B cell subsets present in
peripheral blood from S. haematobium infected and
uninfected schoolchildren living in an endemic area in
Lambare´ne´, Gabon. Children with schistosomiasis had
an increased frequency of various memory B cell
subsets, including subsets associated with B cell
exhaustion, and a concomitant decrease in naive B
cells. To study the effect of Schistosoma infection on B
cells in more detail we isolated peripheral blood B cells
and found that B cells from infected children had a
reduced capacity to proliferate and produce TNF-a in
response to both B cell receptor and Toll-like receptor
stimulation. These results provide new insights into the
role of B cells in the host immune response to
schistosomiasis and may provide a novel target for
therapeutic strategies.
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eF450 (20Raj1, eBioscience) and anti-TNF-a-biotin (MAB11,
eBioscience) followed by second incubation with streptavidin-
Qdot525 (Invitrogen).
Characterization of B cells in peripheral blood
For immunophenotyping freshly isolated PBMCs were fixed in
2.4% formaldehyde (Sigma-Aldrich) for 15 minutes at room
temperature and, subsequently, frozen in RPMI 1640 medium
supplemented with 20% FCS and 10% DMSO and stored at
280uC until FACS analysis. After thawing, cells were washed and
stained for 30 minutes with anti-CD19-PB (HIB19, eBioscience),
anti-CD21-FITC (LT21, BioLegend), anti-CD27-APC (L128, BD
Biosciences), anti-CD27-APC/eF780 (O323, eBioscience), anti-
HLA-DR-APC/Cy7 (L243, BioLegend) and anti-IgD-biotin (IA6-
2, BD Biosciences) followed by second incubation with streptavi-
din-Qdot525 (Invitrogen). Anti-FCRL4-biotin was kindly provided
by M. Cooper (Emory University School of Medicine, Atlanta,
GA, USA). Alternatively, cells were stained with anti-CD19-
BV510 (HIB19, BioLegend), anti-IgA-FITC, anti-IgA-PE (both
IS11-8E10, Miltenyi Biotec), anti-CD21-PE/Cy7 (LT21), anti-
CD23-APC (EDVCS5), anti-CD27-PerCP/Cy5.5 (L128), anti-
CD38-APC/Cy7 (HB7), anti-IgD-PE/CF594 (IA6-2), anti-IgG-
PE (G18-145) and anti-IgM-V450 (G20-127) (all from BD
Biosciences). Cells were acquired on FACSCanto II and LSR
Fortessa flow cytometers (both from BD Biosciences).
Statistical analysis
Differences between study groups were tested using Fisher’s
exact test for gender and co-infections and by Mann-Whitney U
test for Schistosoma infection intensity. Age was normally distributed
and differences between infection groups were tested using the
independent student’s T test. Serological and cellular differences
between infection groups were tested by the Mann-Whitney U
test. Differences within the same group between baseline and
follow-up were compared by Wilcoxon matched pairs test. P-
values less than 0.05 were considered significant and less than 0.1 a
trend. *** p,0.001, ** p,0.01, * p,0.05 and # p,0.1.
Results
Study population characteristics
We recruited S. haematobium-infected (N= 29) and -uninfected
(N= 27) schoolchildren (8–16 years old) for phenotypic B cell
analysis. From these, we selected 10 from each group for more
extensive immunological analyses and performed follow-up studies
six months later on 7 infected children treated with 3 rounds of
praziquantel and 8 uninfected children. Following treatment all S.
haematobium-infected children were infection free. As described in
Table 1, there were no significant differences between the two
groups in the prevalence and infection intensity of other parasitic
infections such as P. falciparum, A. lumbricoides, T. trichiura or
hookworm. Furthermore, age and gender were comparable
between the two groups.
Serum immunoglobulin levels
In schistosomiasis, resistance is acquired slowly and it is not
clear how the B cell compartment and B cell function are affected.
To gain insight into global B cell function during S. haematobium
infection we studied immunoglobulin isotypes and IgG subclasses
in serum. Consistent with previously published data [43], IgG4
levels were increased in S. haematobium-infected compared to
uninfected children and were significantly reduced following
praziquantel treatment (Figure 1). No significant differences were
observed in serum IgM, IgG1, IgG2, IgG3, IgA and IgE between
the groups.
B cell inflammatory cytokine response, activation and
proliferation
To address whether B cell function was altered during
Schistosoma infection, we measured in vitro cytokine responses,
proliferation and activation markers of peripheral blood B cells in
response to BCR (anti-IgG/IgM) and TLR9 (CpG) signaling by
flow cytometry in uninfected and infected children. We first
focused on responses in uninfected children. Intracellular produc-
tion of the pro-inflammatory cytokine TNF-a and expression of
surface CD23, an indicator of TLR activation [44], were
significantly induced by BCR and TLR9 engagement; dual
receptor engagement did not further increase these levels
(Figure 2A, B and S1A, B). Intracellular Ki-67, a marker of
proliferation, was not induced by BCR stimulation alone, but was
increased following CpG stimulation, and as expected [45], dual
BCR and TLR engagement was required for optimal B cell
proliferation (Figure 2C and S1C). Frequencies of unstimulated B
cells that produced TNF-a, expressed CD23 or were positive for
Ki-67 did not differ between infected and uninfected children. As
Table 1. Characteristics of the study population.
S. haematobium infected S. haematobium uninfected p value
N 29 27
Age in years (mean (SD)) 11.36 (2.46) 11.7 (1.82) 0.887*
Male/female 18/11 14/13 0.590#
Egg counts (median (range)) 11 (1–1000) 0 0.000‘
Co-infections
Plasmodium falciparum 5/28 1/26 0.194#
Ascaris lumbricoides 5/23 5/23 1.000#
Trichuris trichiura 6/23 10/23 0.353#
Hookworm 3/23 1/20 0.610#
Co-infections are depicted as number of participants infected out of total number of participants tested.
*independent student’s T test;
#Fisher’s exact test;
‘Mann-Whitney U test.
doi:10.1371/journal.pntd.0002094.t001
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TNF-a production and CD23 expression levels were highest
following CpG stimulation, with no significant enhancement when
combined with anti-IgG/IgM co-stimulation, we focused on CpG
stimulations for comparison between infected and uninfected
children. TNF-a-producing B cell frequencies were significantly
lower in infected children as compared to uninfected children
(Figure 2D), and this was not upregulated upon treatment. In
contrast, CD23-expressing B cell frequencies were significantly
elevated (Figure 2E) and Ki-67+ B cells significantly reduced
(Figure 2F) in the infected children; both were restored following
praziquantel treatment to levels observed in the uninfected
children. Baseline frequencies of CD23+ B cells in ex-vivo PBMCs
did not differ between schistosome-infected children and healthy
controls, 33.9% versus 40.6% respectively (p = 0.932; data not
shown). Taken together, these data suggest that Schistosoma
infection leads to alterations in B cell responses, and that some
of these changes are long lasting and persist at least six months
after removal of infection.
B cell subpopulation analysis
To further explore schistosome-induced alterations in the B cell
compartment, we next compared circulating B cell subsets in
peripheral blood between infected and uninfected children by flow
cytometry. No statistically significant differences in the proportion
of total peripheral B cells were found between schistosome-infected
children and healthy controls, 15.2% versus 13.7% respectively
(p = 0.776). Four distinct CD19+ B cell subsets can be distin-
guished by additional expression of CD27 and IgD [20]
(Figure 3A). These are defined as naive B cells (CD272IgD+),
non-switched MBCs (CD27+IgD+) also referred to as marginal
zone-like B cells, switched MBCs (CD27+IgD2), and double
negative MBCs (CD272IgD2). The proportion of switched MBCs
(Figure 3B) and double negative MBCs (Figure 3D) was
significantly increased in schistosome-infected children and these
levels were significantly reduced to levels comparable to the
uninfected control group following treatment. Concomitantly
there was a trend toward a lower percentage of naive B cells
(p = 0.062) (Figure 3E) in schistosome-infected children and
following treatment the level of naive B cells was significantly
increased. No differences were observed in the levels of non-
switched MBCs (Figure 3C). Interestingly, we noted a positive
correlation between total serum IgG4 levels and the percentage of
switched MBCs (Spearman r=0.407, p,0.05) as well as a trend
with DN MBCs (Spearman r=0.330, p = 0.056) and a negative
correlation with naive B cells (Spearman r=20.392, p,0.05).
To further investigate immunoglobulin expression on B cells
we evaluated an additional 8 schistosome-infected children and 8
endemic controls with an antibody panel that included a brighter
CD27 antibody (Figure S2A). We found similar differences with
respect to an increase in the DN MBCs (Figure S2D) and a
decrease in naive B cells (Figure S2E) in schistosome-infected
children. Although the switched MBCs (Figure S2B) did not differ
significantly in this cohort, when grouped with the original data
(from Figure 3) the overall comparison remained significant. We
first evaluated immunoglobulin levels on CD27+ B cells [46] and
found no differences in the proportion of non-switched IgM+
MBCs (Figure 4A), or switched IgA+ (Figure 4B) and IgG+
(Figure 4C) MBCs between schistosome-infected and -uninfected
children. We next assessed immunoglobulin expression on the
double negative MBCs (CD272IgD2) and while there were no
differences in the proportion of either IgM+ (Figure 4D) or IgA+
(Figure 4E) DN MBCs, the proportion of IgG+ DN MBCs was
significantly increased in schistosome-infected children
(Figure 4F). The majority of the DN MBCs were class-switched
(median, 53.7%) with only 8.7% IgM+ cells, which may
potentially be a mixture of naive and non-switched MBCs,
confirming their status as memory B cells. Similar differences in
immunoglobulin expression were observed on atypical MBCs
(data not shown).
In addition to the classical characterization of the memory B cell
subsets, co-staining of CD27 and CD21 [21] can be performed to
identify four B cell subsets (Figure 5A): 1) naive B cells
(CD272CD21+); 2) activated MBCs (CD27+CD212); 3) classical
MBCs (CD27+CD21+) and 4) atypical MBCs (CD272CD212).
The proportion of activated MBCs (Figure 5B) was significantly
increased and there was a trend toward a higher percentage of
atypical MBCs (p = 0.058) (Figure 5D) in peripheral blood of
schistosome-infected children and levels of both were significantly
reduced following clearance of infection. Similarly the level of
naive B cells was significantly increased (Figure 5E) following
treatment, while no differences were found in the proportion of
classical MBCs either between the groups or at different time
points (Figure 5C). While CD10, a marker of immature and
germinal center B cells, was not included in these panels separate
Figure 1. Serum immunoglobulin analysis. Serum samples were analyzed for total human IgM, IgG1, IgG2, IgG3, IgG4, IgA by Luminex and IgE
by ELISA. Bars represent median with interquartile range. Number of donors in each group: baseline S.h. 2ve n= 9, baseline S.h. +ve n= 10, follow-up
S.h. 2ve n= 8 and follow-up S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g001
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analysis showed the level of immature and germinal center B cells
within our population to be ,2.75% (median) with no differences
between schistosome-infected and -uninfected children, 2.7% and
2.8% respectively (p = 0.798). To study the nature of atypical
MBCs (CD272CD212), we determined the expression levels of
HLA-DR and FCRL4, a cell surface marker that is characteristic
for exhausted MBCs. In line with previous reports [23,25],
FCRL4 was expressed at significantly higher levels on atypical
MBCs compared to classical MBCs (CD272CD212) and naive B
cells (CD272CD21+) in uninfected children (Figure S3A).
Furthermore, HLA-DR expression was significantly higher on
atypical MBCs and naive B cells as compared to classical MBCs
(Figure S3B). Both markers were not differentially expressed
between B cell subsets of uninfected and infected children (data
not shown). Taken together, these data show that Schistosoma
infection leads to changes in the distribution of peripheral B cell
subsets and that praziquantel treatment leads to a reduction of
various memory B cell subsets and an increase of naive B cells.
B cell subset inflammatory cytokine response, activation
and proliferation
To investigate whether changes in TNF-a, Ki-67 and CD23
observed in total B cells were attributed to specific B cell subsets,
we extended our flow cytometry analysis to include the various B
cell subsets defined by CD21 and CD27 expression, first gating on
CD102 B cells. Isolated B cells were stimulated with anti-IgG/
IgM, CpG or a combination of the two and stained for the
expression of intracellular TNF-a and Ki-67 and surface CD23.
We found that CpG stimulation alone or in combination with anti-
IgG/IgM resulted in significant loss of CD27 expression (data not
shown); as a result it was no longer possible to differentiate the four
B cell subpopulations with the same criteria as in Figure 5A. We
therefore focused on anti-IgG/IgM-stimulated cells, as here we
could still distinguish the four B cell populations and analyzed the
responses of the various B cell subsets in uninfected children. We
found very high frequencies of TNF-a-producing activated MBCs,
Figure 2. B cell inflammatory cytokine response, activation and proliferation. Total peripheral blood B cells were cultured with anti-IgG/
IgM (2.5 mg/ml), CpG (5 mg/ml) or anti-IgG/IgM plus CpG for two days, restimulated with PMA/Ionomycin/LPS and BrefA and fixed. Levels of
intracellular TNF-a (A), CD23 expression (B) and intracellular Ki-67 (C) were measured in S. haematobium-uninfected children by flow cytometry. Levels
of intracellular TNF-a (D), CD23 expression (E) and intracellular Ki-67 (F) following CpG stimulation in infected and uninfected children at baseline and
follow-up. Horizontal bars represent median. Number of donors in each group: baseline S.h. 2ve n= 10, baseline S.h. +ve n= 9, follow-up S.h. 2ve
n= 7 and follow-up S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g002
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Figure 3. MBC analysis. PBMC were fixed and stained with B cell phenotyping markers (CD19, CD27 and IgD) and analyzed for B cell subsets by
flow cytometry. B cell subset analysis was performed as shown in (A) (representative S. haematobium-uninfected child). Proportion of CD19-gated
cells that were CD27+IgD2 (B, switched MBC), CD27+IgD+ (C, non-switched MBC), CD272IgD2 (D, double negative MBC), and CD272IgD+ (E, naive B
Effects of Schistosomiasis on Human B Cells
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followed by classical MBCs and atypical MBCs and observed the
lowest frequencies among naive B cells (Figure 6A). When
comparing the various B cell subsets for their ability to respond
to BCR engagement between infected and uninfected children, we
observed significantly less TNF-a+ activated MBCs (Figure 6B)
and classical MBCs (Figure 6C) and a trend for lower levels in the
naive B cells and atypical MBCs in the infected children (data not
shown). These data reflect the reduced TNF-a production in the
total B cell population observed earlier (Figure 2A), and likewise
the levels of TNF-a following treatment were not restored to levels
observed in the uninfected children for any of the subsets
(Figure 6B, C). These data point at a reduced capacity of B cells
from infected children to produce TNF-a in response to anti-IgG/
IgM stimulation which extends to all B cell subsets studied. While
classical MBCs had higher frequencies of CD23 and Ki-67
expressing cells, no differences were observed between infected
and uninfected children for any of the subsets or upon treatment.
Discussion
Although many studies have investigated the types and
frequencies of various immune cell subsets, including T cells and
DCs [47–49], little is known about the human B cell compartment
during the course of S. haematobium infection. In the present study,
we have analyzed innate and antibody-driving pathways in total B
cells and different peripheral B cell subsets and compared their
responses between infected and uninfected Gabonese schoolchil-
dren. We found that S. haematobium infection leads to changes in B
cell function as well as alterations of the total B cell compartment
and these changes are not restricted to a single B cell population.
When evaluating B cell functionality, we found significantly
lower frequencies of TNF-a-producing and Ki-67+ proliferating B
cells in S. haematobium-infected children (Figure 2D and F).
Interestingly, Ki-67+ B cell frequencies were restored to levels
comparable to uninfected children following anti-schistosome
treatment (Figure 2F), but TNF-a levels remained significantly
lower (Figure 2D). The downregulation of TNF-a and B cell
proliferation in S. haematobium positive children may be a result of
immunomodulation induced by the parasite to prolong its survival.
This would be in line with studies showing that TNF-a might play
an important role in immunity to helminths: TNF-a production by
B cells was necessary for sustained antibody production and
establishment of protective immunity to Heligmosomoides polygyrus
[50]. Moreover, B-cell derived TNF-a has been shown to enhance
IFN-c production by T cells in Toxoplasma gondii-infected mice [51]
and it is thought that an effective Th1 response is key to natural
acquisition of resistance against Schistosoma infection [12,52].
Therefore, it is tempting to suggest that the long lasting reduction
cells) were determined for S. haematobium-infected and uninfected children at baseline and follow-up. (B, C, D, E) Horizontal bars represent median.
Number of donors in each group: baseline S.h. 2ve n= 19, baseline S.h. +ve n= 21, follow-up S.h. 2ve n= 8 and follow-up S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g003
Figure 4. Expression of IgM, IgA and IgG on CD27+ and DN MBCs. PBMC were fixed and expression of IgM, IgA and IgG on CD27+ B cells was
evaluated [46]. Proportions of CD19+ gated cells that were IgM+IgD2CD27+ (A), IgA+IgM2IgD2CD27+ (B), and IgG+IgM2IgD2CD27+ (C) were
determined for S. haematobium-infected and uninfected children at baseline. For immunoglobulin expression on DN MBCs, PBMC were fixed and
stained with B cell subset markers (CD19, IgD and CD27) and DN MBCs measured for IgM, IgA and IgG expression. Proportion of CD19+CD272IgD2-
gated cells that were IgM+ (D), IgA+ (E) and IgG+ (F) were determined for S. haematobium-infected and uninfected children at baseline. Horizontal bars
represent median. Number of donors in each group: S.h. 2ve n= 8 and S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g004
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Figure 5. Atypical MBC analysis. PBMC were fixed and stained with B cell phenotyping markers (CD19, CD21 and CD27) and analyzed for B cell
subsets by flow cytometry. B cell subset analysis was performed as shown in (A) (representative S. haematobium-uninfected child). Proportion of
CD19-gated cells that were CD27+CD212 (B, activated MBC), CD27+CD21+ (C, classical MBC), CD272CD212 (D, atypical MBC), and CD272CD21+ (E,
naive B cells) were determined for S. haematobium-infected and uninfected children at baseline and follow-up. (B, C, D, E) Horizontal bars represent
median. Number of donors in each group: baseline S.h. 2ve n= 19, baseline S.h. +ve n= 20, follow-up S.h. 2ve n= 8 and follow-up S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g005
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in B cell capacity to produce TNF-a, as demonstrated post-
treatment, may in part contribute to the slow development of
resistance to Schistosoma infection, although presence of other
unknown concomitant viral or fungal infections may also play a
role.
In the current study we analyzed CD23 as a TLR activation
marker on B cells, however CD23 is also correlated with the
development of resistance to Schistosoma infection [14]. Further-
more, cross-linking of CD23-bound IgE by antigen may induce
cellular activation and increased IgE production [53,54]. Repeat-
ed rounds of treatment and S. mansoni re-infection led to a gradual
increase in CD23 expression and resistance in a cohort of Kenyan
children [15]. This seems partly in contrast to our results, as the
elevated CD23 levels in infected children are reduced after
treatment. However in the Kenyan cohort levels of CD23
expression were evaluated in fresh whole blood samples while
here we measured CD23 expression on stimulated B cells as a
marker of B cell activation. Baseline levels of CD23 expression on
ex-vivo PBMCs in our population did not differ, however CD23
levels following treatment were not measured. It would therefore
be of interest to measure the dynamics of CD23 expression in our
population longitudinally following multiple rounds of treatment.
Perturbations in the frequency of various B cell subsets have
been demonstrated in a number of disease states [34] and here we
found an increase in the switched MBCs, the double negative
MBCs and activated MBCs, as well as a trend toward a higher
percentage of atypical MBCs and a concomitant decrease of naive
B cells in schistosome-infected children. All populations were
restored to levels observed in uninfected children following
treatment. It is unclear whether the increase in naive B cells
following treatment is due to de novo generation of B cells from the
bone marrow, expansion of the pre-existing naive B cell
population or results from a decrease in the levels of the other
subsets.
It has been shown that in HIV- [21] and malaria-infected
individuals [23,24] an exhausted/atypical memory B cell popu-
lation (CD272CD212), was greatly expanded and that these cells
were hyporesponsive and had a decreased ability to differentiate
into antibody secreting cells, contributing to the diminished
pathogen-specific antibody responses in infected individuals.
Likewise, it has been suggested that double negative (CD272IgD2)
MBCs, which are increased in SLE, might be exhausted/
terminally differentiated memory B cells [55,56]. In chronic S.
haematobium infection we similarly see an expansion of both double
negative and atypical MBCs. The overlap between these two
MBC subpopulations, their capacity to produce schistosome-
specific antibodies or the exact characteristics of their ‘exhausted’
state are currently not clear.
Nevertheless it is interesting to note that schistosome-infected
children carry higher frequencies of IgG+ double negative
(CD272IgD2) MBCs compared to uninfected children, whereas
no differences are observed in the levels of IgM+ or IgA+ DN
MBCs (Figure 4). Similarly, no differences were observed in total
serum IgM, IgA nor IgG1, IgG2 and IgG3, whereas significant
Figure 6. B cell subset inflammatory cytokine response, activation and proliferation. Total peripheral blood B cells were cultured with
anti-IgG/IgM (2.5 mg/ml) for two days, restimulated with PMA/Ionomycin/LPS and BrefA, fixed and stained with B cell subset markers (CD10, CD19,
CD21 and CD27) and levels of intracellular TNF-a was measured in S. haematobium-uninfected children by flow cytometry (A). Levels of intracellular
TNF-a in activated MBCs (B) and classical MBCs (C) in infected and uninfected children at baseline and follow-up. Horizontal bars represent median.
Number of donors in each group: baseline S.h. 2ve n= 10, baseline S.h. +ve n= 9, follow-up S.h. 2ve n= 7 and follow-up S.h. +ve n= 7.
doi:10.1371/journal.pntd.0002094.g006
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differences were only observed in IgG4 (Figure 1). Interestingly,
serum levels of IgG4 were significantly decreased following
treatment and correlated with a concomitant decrease in the
frequency of the DN MBCs, suggesting that the increase in IgG+
DN MBCs may be predominantly due to an increase in IgG4-
expressing B cells. As IgG4 is associated with susceptibility and IgE
with resistance to Schistosoma infection, it would be of interest to
study these isotypes on the different memory B cell populations in
exposed but resistant individuals. These studies could shed further
light on the various ways in which S. haematobium infection
modulates the immune response providing further information for
the design of an effective vaccine.
Although the function of double negative and atypical MBCs is
not yet clear in the context of Schistosoma infection, it is tempting to
speculate that these may be expanded as a result of the chronic
nature and strong immunomodulation of S. haematobium infection.
These memory B cells may limit the associated pathology while at
the same time limiting the effectiveness of the immune response
against the parasite. Indeed, a protective role against malaria
infection has been proposed for atypical MBCs through regulation
of the host’s immune response [23,24]. This parallels FCRL4+
tissue-like MBCs in lymphoid tissue, which may protect against
invading pathogens directly or indirectly through the secretion of
cytokines and their influence on other immune cell types [25,26].
A recent study has highlighted the dual nature of B cells in
immune responses demonstrating that the same B cells may play
both a regulatory (IL-10) or pathogenic (IL-6) role depending on
the signals received [57]. It would be of interest to investigate
concomitantly the production of both IL-6 and IL-10 by the
various MBC subsets and naive B cells to see the balance between
pro- and anti-inflammatory B cell responses during Schistosoma
infection.
As demonstrated above S. haematobium infection leads to
significant changes in B cell function as well as alterations of the
B cell compartment in peripheral blood of infected children as
compared to healthy controls. Further studies are needed to define
whether these changes in the frequency of the various subsets have
functional consequences and what their role is in the immune
response against S. haematobium.
Supporting Information
Figure S1 Gating strategy for B cell inflammatory
cytokine response, activation and proliferation. Total
peripheral blood B cells were cultured with anti-IgG/IgM (2.5 mg/
ml), CpG (5 mg/ml) or anti-IgG/IgM plus CpG for two days,
restimulated with PMA/Ionomycin/LPS and BrefA and fixed.
Levels of intracellular TNF-a (A), CD23 expression (B) and
intracellular Ki-67 (C) were gated according to the gating strategy
depicted in this figure (representative S. haematobium-uninfected
child).
(TIF)
Figure S2 MBC analysis. PBMC were fixed and stained with
B cell phenotyping markers (CD19, CD27 and IgD) and analyzed
for B cell subsets by flow cytometry. B cell subset analysis was
performed as shown in (A) (representative S. haematobium-
uninfected child). Proportion of CD19-gated cells that were
CD27+IgD2 (B, switched MBC), CD27+IgD+ (C, non-switched
MBC), CD272IgD2 (D, double negative MBC), and CD272IgD+
(E, naive B cells) were determined for S. haematobium-infected and
uninfected children at baseline. (B, C, D, E) Horizontal bars
represent median. Number of donors in each group: baseline S.h.
2ve n= 8 and S.h. +ve n= 8.
(TIF)
Figure S3 Expression of FCRL4 and HLA-DR on B cell
subpopulations. PBMC were fixed and stained with B cell
subset markers (CD19, CD21 and CD27) and measured for
FCRL4 (A) and HLA-DR (B) expression in S. haematobium-
uninfected children by flow cytometry. Histograms of MFI
underneath are from a representative child. Horizontal bars
represent median. Number of donors: baseline S.h. 2ve n= 19.
(TIF)
Acknowledgments
We thank the study participants from Lambare´ne´ and PK15 in Gabon for
volunteering to participate in this study and all the field workers involved.
Furthermore, we thank Serge A. Versteeg for performing the IgE ELISA.
Author Contributions
Conceived and designed the experiments: LAL AAAMY HHS. Performed
the experiments: LAL UAN ENF JJH RBAP LM. Analyzed the data: LAL
JJH LEPMvdV MCvZ MY HHS. Contributed reagents/materials/
analysis tools: PGK MCvZ AAA MY. Wrote the paper: LAL HHS.
References
1. World Health Organization (2012) Schistosomiasis. Available: http://www.who.
int/mediacentre/factsheets/fs115/en/index.html. Accessed 26 June 2012.
2. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, et al. (2009)
Immunopathogenesis of human schistosomiasis. Parasite Immunol 31: 163–176.
3. van Riet E, Hartgers FC, Yazdanbakhsh M (2007) Chronic helminth infections
induce immunomodulation: consequences and mechanisms. Immunobiology
212: 475–490.
4. Allen JE, Maizels RM (2011) Diversity and dialogue in immunity to helminths.
Nat Rev Immunol 11: 375–388.
5. Woolhouse ME, Taylor P, Matanhire D, Chandiwana SK (1991) Acquired
immunity and epidemiology of Schistosoma haematobium. Nature 351: 757–
759.
6. Yazdanbakhsh M, Sacks DL (2010) Why does immunity to parasites take so long
to develop? Nat Rev Immunol 10: 80–81.
7. Jankovic D, Wynn TA, Kullberg MC, Hieny S, Caspar P, et al. (1999) Optimal
vaccination against Schistosoma mansoni requires the induction of both B cell-
and IFN-gamma-dependent effector mechanisms. J Immunol 162: 345–351.
8. Sher A, Smithers SR, Mackenzie P (1975) Passive transfer of acquired
resistance to Schistosoma mansoni in laboratory mice. Parasitology 70 Part 3:
347–357.
9. Mangold BL, Dean DA (1986) Passive transfer with serum and IgG antibodies of
irradiated cercaria-induced resistance against Schistosoma mansoni in mice.
J Immunol 136: 2644–2648.
10. Vereecken K, Naus CW, Polman K, Scott JT, Diop M, et al. (2007) Associations
between specific antibody responses and resistance to reinfection in a Senegalese
population recently exposed to Schistosoma mansoni. Trop Med Int Health 12:
431–444.
11. Khalife J, Dunne DW, Richardson BA, Mazza G, Thorne KJ, et al. (1989)
Functional role of human IgG subclasses in eosinophil-mediated killing of
schistosomula of Schistosoma mansoni. J Immunol 142: 4422–4427.
12. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis.
Clin Microbiol Rev 21: 225–242.
13. Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, et al. (1988) IgE
production by normal human lymphocytes is induced by interleukin 4 and
suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl
Acad Sci U S A 85: 6880–6884.
14. Mwinzi PN, Ganley-Leal L, Black CL, Secor WE, Karanja DM, et al. (2009)
Circulating CD23+ B cell subset correlates with the development of resistance to
Schistosoma mansoni reinfection in occupationally exposed adults who have
undergone multiple treatments. J Infect Dis 199: 272–279.
15. Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, et al. (2010)
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B
cells in a cohort of Kenyan children undergoing repeated treatment and
reinfection with Schistosoma mansoni. J Infect Dis 202: 399–405.
16. Harris N, Gause WC (2011) To B or not to B: B cells and the Th2-type immune
response to helminths. Trends Immunol 32: 80–88.
Effects of Schistosomiasis on Human B Cells
PLOS Neglected Tropical Diseases | www.plosntds.org 10 March 2013 | Volume 7 | Issue 3 | e2094
17. van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans
AK, et al. (2012) Schistosomes induce regulatory features in human and mouse
CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T
cells. PLoS One 7: e30883.
18. Crotty S, Ahmed R (2004) Immunological memory in humans. Semin Immunol
16: 197–203.
19. Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, et al. (1997) B
cell subpopulations separated by CD27 and crucial collaboration of CD27+ B
cells and helper T cells in immunoglobulin production. Eur J Immunol 27:
2073–2079.
20. Klein U, Rajewsky K, Kuppers R (1998) Human immunoglobulin (Ig)M+IgD+
peripheral blood B cells expressing the CD27 cell surface antigen carry
somatically mutated variable region genes: CD27 as a general marker for
somatically mutated (memory) B cells. J Exp Med 188: 1679–1689.
21. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, et al. (2008) Evidence for
HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment
in HIV-infected viremic individuals. J Exp Med 205: 1797–1805.
22. Moir S, Fauci AS (2009) B cells in HIV infection and disease. Nat Rev Immunol
9: 235–245.
23. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, et al. (2009) Atypical
memory B cells are greatly expanded in individuals living in a malaria-endemic
area. J Immunol 183: 2176–2182.
24. Weiss GE, Clark EH, Li S, Traore B, Kayentao K, et al. (2011) A positive
correlation between atypical memory B cells and Plasmodium falciparum
transmission intensity in cross-sectional studies in Peru and Mali. PLoS One 6:
e15983.
25. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, et al. (2005) Expression
of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based
population of memory B cells. J Exp Med 202: 783–791.
26. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, et al. (2008)
Discriminating gene expression profiles of memory B cell subpopulations. J Exp
Med 205: 1807–1817.
27. Sugalski JM, Rodriguez B, Moir S, Anthony DD (2010) Peripheral blood B cell
subset skewing is associated with altered cell cycling and intrinsic resistance to
apoptosis and reflects a state of immune activation in chronic hepatitis C virus
infection. J Immunol 185: 3019–3027.
28. Booth J, Wilson H, Jimbo S, Mutwiri G (2011) Modulation of B cell responses by
Toll-like receptors. Cell Tissue Res 343: 131–140.
29. Bekeredjian-Ding I, Jego G (2009) Toll-like receptors–sentries in the B-cell
response. Immunology 128: 311–323.
30. Nemazee D, Gavin A, Hoebe K, Beutler B (2006) Immunology: Toll-like
receptors and antibody responses. Nature 441: E4.
31. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors.
Nature 438: 364–368.
32. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, et al. (2007)
TLR9 stimulation drives naive B cells to proliferate and to attain enhanced
antigen presenting function. Eur J Immunol 37: 2205–2213.
33. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological
memory by polyclonal activation of human memory B cells. Science 298: 2199–
2202.
34. Anolik JH, Looney RJ, Lund FE, Randall TD, Sanz I (2009) Insights into the
heterogeneity of human B cells: diverse functions, roles in autoimmunity, and
use as therapeutic targets. Immunol Res 45: 144–158.
35. Mbow M, Larkin BM, Meurs L, Wammes LJ, de Jong SE, et al. (2012) T-Helper
17 Cells Are Associated With Pathology in Human Schistosomiasis. J Infect Dis.
jis654.
36. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, et al. (2002) Cytokine
regulation of periportal fibrosis in humans infected with Schistosoma mansoni:
IFN-gamma is associated with protection against fibrosis and TNF-alpha with
aggravation of disease. J Immunol 169: 929–936.
37. Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, et al. (2004) Periportal
fibrosis in human Schistosoma mansoni infection is associated with low IL-10,
low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and
gender. J Immunol 172: 1295–1303.
38. van den Biggelaar AH, Lopuhaa C, van Ree R, van der Zee JS, Jans J, et al.
(2001) The prevalence of parasite infestation and house dust mite sensitization in
Gabonese schoolchildren. Int Arch Allergy Immunol 126: 231–238.
39. van Riet E, Adegnika AA, Retra K, Vieira R, Tielens AG, et al. (2007) Cellular
and humoral responses to influenza in gabonese children living in rural and
semi-urban areas. J Infect Dis 196: 1671–1678.
40. Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool
thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao
Paulo 14: 397–400.
41. Polderman AM, Krepel HP, Baeta S, Blotkamp J, Gigase P (1991)
Oesophagostomiasis, a common infection of man in northern Togo and Ghana.
Am J Trop Med Hyg 44: 336–344.
42. Planche T, Krishna S, Kombila M, Engel K, Faucher JF, et al. (2001)
Comparison of methods for the rapid laboratory assessment of children with
malaria. Am J Trop Med Hyg 65: 599–602.
43. Butterworth AE, Dunne DW, Fulford AJ, Thorne KJ, Gachuhi K, et al. (1992)
Human immunity to Schistosoma mansoni: observations on mechanisms, and
implications for control. Immunol Invest 21: 391–407.
44. Hanten JA, Vasilakos JP, Riter CL, Neys L, Lipson KE, et al. (2008)
Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC
Immunol 9: 39.
45. Ruprecht CR, Lanzavecchia A (2006) Toll-like receptor stimulation as a third
signal required for activation of human naive B cells. Eur J Immunol 36: 810–
816.
46. Berkowska MA, Driessen GJ, Bikos V, Grosserichter-Wagener C, Stamatopou-
los K, et al. (2011) Human memory B cells originate from three distinct germinal
center-dependent and -independent maturation pathways. Blood 118: 2150–
2158.
47. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M (1998) Antigen-
specific proliferation and interferon-gamma and interleukin-5 production are
down-regulated during Schistosoma haematobium infection. J Infect Dis 177:
1433–1437.
48. Everts B, Adegnika AA, Kruize YC, Smits HH, Kremsner PG, et al. (2010)
Functional impairment of human myeloid dendritic cells during Schistosoma
haematobium infection. PLoS Negl Trop Dis 4: e667.
49. Nausch N, Midzi N, Mduluza T, Maizels RM, Mutapi F (2011) Regulatory and
activated T cells in human Schistosoma haematobium infections. PLoS One 6:
e16860.
50. Wojciechowski W, Harris DP, Sprague F, Mousseau B, Makris M, et al. (2009)
Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus.
Immunity 30: 421–433.
51. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, et al. (2007) B
cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated
mechanism. J Immunol 179: 4857–4866.
52. Correa-Oliveira R, Caldas IR, Gazzinelli G (2000) Natural versus drug-induced
resistance in Schistosoma mansoni infection. Parasitol Today 16: 397–399.
53. Onguru D, Liang Y, Elliot J, Mwinzi P, Ganley-Leal L (2011) CD23b isoform
expression in human schistosomiasis identifies a novel subset of activated B cells.
Infect Immun 79: 3770–3777.
54. Griffith QK, Liang Y, Onguru DO, Mwinzi PN, Ganley-Leal LM (2011) CD23-
bound IgE augments and dominates recall responses through human naive B
cells. J Immunol 186: 1060–1067.
55. Bulati M, Buffa S, Candore G, Caruso C, Dunn-Walters DK, et al. (2011) B cells
and immunosenescence: a focus on IgG+IgD-CD272 (DN) B cells in aged
humans. Ageing Res Rev 10: 274–284.
56. Rodriguez-Bayona B, Ramos-Amaya A, Perez-Venegas JJ, Rodriguez C, Brieva
JA (2010) Decreased frequency and activated phenotype of blood CD27 IgD
IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus
patients. Arthritis Res Ther 12: R108.
57. Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, et al. (2012) B cell
depletion therapy ameliorates autoimmune disease through ablation of IL-6-
producing B cells. J Exp Med 209: 1001–1010.
Effects of Schistosomiasis on Human B Cells
PLOS Neglected Tropical Diseases | www.plosntds.org 11 March 2013 | Volume 7 | Issue 3 | e2094
